​

Korro Bio (KRRO) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChart

KRRO Stock Forecast

Korro Bio (KRRO) stock forecast, based on 11 Wall Street analysts, predicts a 12-month average price target of $19.67, with a high of $30.00 and a low of $10.00. This represents a 60.44% increase from the last price of $12.26.

$10 $26 $42 $58 $74 $90 High: $30 Avg: $19.67 Low: $10 Last Closed Price: $12.26

KRRO Stock Rating

Korro Bio stock's rating consensus is Buy, based on 11 Wall Street analysts. The breakdown includes 1 Strong Buy (9.09%), 7 Buy (63.64%), 3 Hold (27.27%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 11 0 3 7 1 Strong Sell Sell Hold Buy Strong Buy

KRRO Price Target Upside V Benchmarks

TypeNameUpside
StockKorro Bio60.44%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts667
Avg Price Target$19.67$19.67$20.43
Last Closing Price$12.26$12.26$12.26
Upside/Downside60.44%60.44%66.64%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Feb, 26144--9
Jan, 26--9--9
Dec, 25--9--9
Nov, 2536---9
Oct, 2536---9
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jan 29, 2026H.C. Wainwright$20.00$11.6971.09%63.13%
Jan 29, 2026Chardan Capital$15.00$11.6928.31%22.35%
Jan 28, 2026Yasmeen RahimiPiper Sandler$30.00$11.69156.63%144.70%
Jan 28, 2026Myles MinterWilliam Blair$10.00$11.17-10.47%-18.43%
Jan 28, 2026Oppenheimer$22.00$10.74104.84%79.45%
Jan 27, 2026Steve SeedhouseCantor Fitzgerald$21.00$10.7495.53%71.29%
Apr 16, 2025Keay NakaeChardan Capital$25.00$13.4685.74%103.92%
Oct 21, 2024Luca IssiRBC Capital$105.00$76.9436.47%756.44%
May 15, 2024Kostas BiliourisBMO Capital$120.00$50.05139.76%878.79%
Mar 28, 2024H.C. Wainwright$115.00$88.5329.90%838.01%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jan 29, 2026H.C. WainwrightBuyBuyupgrade
Jan 28, 2026Piper SandlerOverweightOverweightupgrade
Jan 28, 2026William BlairMarket PerformMarket Performhold
Jan 28, 2026Raymond JamesMarket PerformMarket Performhold
Jan 28, 2026OppenheimerOutperformOutperformupgrade
Jan 27, 2026Cantor FitzgeraldOverweightOverweightupgrade
Apr 28, 2025Cantor FitzgeraldOverweightinitialise
Jan 10, 2025OppenheimerOutperforminitialise
Oct 21, 2024Raymond JamesStrong Buyinitialise
Oct 21, 2024RBC CapitalOutperformOutperformhold

Financial Forecast

EPS Forecast

$-85 $-68 $-51 $-34 $-17 $0 Dec 21 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-4.94$-53.09$-9.37----
Avg Forecast$-84.26$-12.68$-9.25$-9.74$-9.10$-10.31$-10.73
High Forecast$-84.26$-12.45$-8.83$-7.92$-6.74$-7.47$-10.73
Low Forecast$-84.26$-12.90$-9.52$-11.06$-11.62$-12.32$-10.73
Surprise %-94.14%318.69%1.30%----

Revenue Forecast

$5M $14M $23M $32M $41M $50M Dec 21 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$14.07M-$2.27M----
Avg Forecast$45.07M-----$9.38M
High Forecast$45.07M-----$9.38M
Low Forecast$45.07M-----$9.38M
Surprise %-68.79%------

Net Income Forecast

$-150M $-120M $-90M $-60M $-30M $0 Dec 21 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-21.96M$-81.17M$-83.58M----
Avg Forecast$-128.87M$-19.38M$-14.03M$-14.51M$-14.04M$-15.13M$-16.41M
High Forecast$-128.87M$-19.04M$-13.51M$-12.11M$-10.30M$-11.42M$-16.41M
Low Forecast$-128.87M$-19.73M$-14.56M$-16.91M$-17.77M$-18.84M$-16.41M
Surprise %-82.96%318.75%495.61%----

KRRO Forecast FAQ

Is Korro Bio stock a buy?

Korro Bio stock has a consensus rating of Buy, based on 11 Wall Street analysts. The rating breakdown includes 1 Strong Buy, 7 Buy, 3 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Korro Bio is a favorable investment for most analysts.

What is Korro Bio's price target?

Korro Bio's price target, set by 11 Wall Street analysts, averages $19.67 over the next 12 months. The price target range spans from $10 at the low end to $30 at the high end, suggesting a potential 60.44% change from the previous closing price of $12.26.

How does Korro Bio stock forecast compare to its benchmarks?

Korro Bio's stock forecast shows a 60.44% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for Korro Bio over the past three months?

  • February 2026: 11.11% Strong Buy, 44.44% Buy, 44.44% Hold, 0% Sell, 0% Strong Sell.
  • January 2026: 0% Strong Buy, 0% Buy, 100.00% Hold, 0% Sell, 0% Strong Sell.
  • December 2025: 0% Strong Buy, 0% Buy, 100.00% Hold, 0% Sell, 0% Strong Sell.

What is Korro Bio’s EPS forecast?

Korro Bio's average annual EPS forecast for its fiscal year ending in December 2025 is $-9.74, marking a 3.95% increase from the reported $-9.37 in 2024. Estimates for the following years are $-9.1 in 2026, $-10.31 in 2027, and $-10.73 in 2028.

What is Korro Bio’s revenue forecast?

Korro Bio's average annual revenue forecast for its fiscal year ending in December 2025 is $0, reflecting a -100.00% decrease from the reported $2.27M in 2024. The forecast for 2026 is $0, followed by $0 for 2027, and $9.38M for 2028.

What is Korro Bio’s net income forecast?

Korro Bio's net income forecast for the fiscal year ending in December 2025 stands at $-14.509M, representing a -82.64% decrease from the reported $-83.581M in 2024. Projections indicate $-14.037M in 2026, $-15.13M in 2027, and $-16.407M in 2028.